The Challenges of Setting Up a Clinical Study with the New European Union Medical Device Regulation

Sílvia Rêgo; Marco Dutra-Medeiros; Francisco Nunes

doi:10.20344/amp.19423

The Challenges of Setting Up a Clinical Study with the New European Union Medical Device Regulation

Authors

Sílvia Rêgo Fraunhofer Portugal AICOS (Fraunhofer Portugal Research Center for Assistive Information and Communication Solutions). Porto; Faculdade de Medicina. Universidade do Porto. Porto.
Marco Dutra-Medeiros Department of Ophthalmology. Centro Hospitalar Universitário Lisboa Central. Lisbon; NOVA Medical School. Universidade NOVA de Lisboa. Lisbon; Portuguese Retina Institute. Lisbon. https://orcid.org/0000-0003-0421-1211
Francisco Nunes Fraunhofer Portugal AICOS (Fraunhofer Portugal Research Center for Assistive Information and Communication Solutions). Porto. https://orcid.org/0000-0002-4913-9412

DOI:

https://doi.org/10.20344/amp.19423

Keywords:

Clinical Research, European Union, Medical Device Legislation

Abstract

N/a.

Downloads

Download data is not yet available.

References

European Union. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017. [cited 2022 Nov 17]. Available from: https://www.legislation.gov.uk/eur/2017/745/contents.

Healthskouts. FDA/CE certified health app database. 2022. [cited 2023 Jan 13]. Available from: https://www.healthskouts.com/certified-apps/.

Malvehy J, Ginsberg R, Sampietro-Colom L, Ficapal J, Combalia M, Svedenhag P. New regulation of medical devices in the EU: impact in dermatology. J Eur Acad Dermatol Venereol. 2022;36:360-4. DOI: https://doi.org/10.1111/jdv.17830

Central Committee on Research Involving Human Subjects. Investigational medical device dossier. 2020. [cited 2022 Nov 17]. Available from: https://english.ccmo.nl/investigators/publications/forms/2020/12/14/d2-imdd-template.

European Commission’s Medical Devices Coordination Group. MDCG 2021-6: Regulation (EU) 2017/745 – Questions & answers regarding clinical investigation. 2021. [cited 2022 Nov 17]. Available from: https://health.ec.europa.eu/system/files/2021-04/mdcg_2021-6_en_0.pdf.

Central Committee on Research Involving Human Subjects. Review of a clinical investigation with a medical device – guidance document for MRECs.

[cited 2022 Nov 17]. Available from: https://english.ccmo.nl/publications/publications/2021/05/17/review-of-a-clinical-investigation-with-a-medicaldevice-–-guidance-document-for-mrecs.

European Union. Directive 2021/20/EC of the European Parliament and of the Council of 4 April 2001. 2001. [cited 2022 Nov 17]. Available from: https://www.legislation.gov.uk/eudr/2001/20/introduction.

International Organization for Standardization. ISO 14155:2020 Clinical investigation of medical devices for human subjects - Good clinical practice.2020. [cited 2022 Nov 20]. Available from: https://www.iso.org/obp/ui/#iso:std:iso:14155:ed-3:v1:en.

Medical Device Directive. Council Directive 93/42/EEC of 14 June 1993 Concerning medical devices. 2017. [cited 2022 Nov 24]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A31993L0042.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. Transforming clinical research in the United States: challenges and opportunities: workshop summary. Washington: National Academies Press; 2010.

Allianz Global Corporate & Specialty. Addressing the challenges of clinical trials insurance. 2022. [cited 2022 Nov 17]. Available from: https://www.agcs.allianz.com/news-and-insights/expert-risk-articles/addressing-challenges-clinical-trials-insurance.html.

Downloads

Published

2023-05-26

How to Cite

Rêgo S, Dutra-Medeiros M, Nunes F. The Challenges of Setting Up a Clinical Study with the New European Union Medical Device Regulation. Acta Med Port [Internet]. 2023 May 26 [cited 2024 Nov. 22];36(7-8):455-7. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/19423

Download Citation

Issue

Vol. 36 No. 7-8 (2023): July-August

Section

Perspective

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.